These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17700052)

  • 41. Bupropion-induced neck and shoulder pain.
    Sansone RA; Sansone LA
    Pharmacopsychiatry; 2009 Sep; 42(5):203-4. PubMed ID: 19724984
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of bupropion on immunodensity of putative imidazoline receptors on platelets of depressed patients.
    Zhu H; Halaris A; Madakasira S; Pazzaglia P; Goldman N; DeVane CL; Andrew M; Reis D; Piletz JE
    J Psychiatr Res; 1999; 33(4):323-33. PubMed ID: 10404470
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Amphetamine-like stimulant cessation in an abusing patient treated with buproprion (Tardiev et al. 2004).
    Berigan T
    Acta Psychiatr Scand; 2004 Oct; 110(4):312; author reply 312. PubMed ID: 15352937
    [No Abstract]   [Full Text] [Related]  

  • 44. Bupropion and panic disorder: case report and review of the literature.
    Serafini G; Pompili M; Fusar-Poli P; Porfiri G; Giordano G; Ferracuti S; Girardi P; Tatarelli R
    J Neuropsychiatry Clin Neurosci; 2011; 23(2):E47-50. PubMed ID: 21677228
    [No Abstract]   [Full Text] [Related]  

  • 45. Bupropion normalizes cognitive performance in patients with depression.
    Gualtieri CT; Johnson LG
    MedGenMed; 2007 Jan; 9(1):22. PubMed ID: 17435629
    [No Abstract]   [Full Text] [Related]  

  • 46. Smoking cessation treatment in a real-life setting: the Greek experience.
    Rovina N; Nikoloutsou I; Dima E; Michailidou M; Roussos C; Gratziou C
    Ther Adv Respir Dis; 2007 Dec; 1(2):93-104. PubMed ID: 19124351
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhancement of noradrenergic neural transmission: an effective therapy of myasthenia gravis: a report on 52 consecutive patients.
    Lechin F; van der Dijs B; Pardey-Maldonado B; John E; Jimenez V; Orozco B; Baez S; Lechin ME
    J Med; 2000; 31(5-6):333-61. PubMed ID: 11508327
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumor necrosis factor-alpha in hepatitis B: potential role for bupropion.
    Kast RE; Altschuler EL
    J Hepatol; 2003 Jul; 39(1):131-3. PubMed ID: 12821057
    [No Abstract]   [Full Text] [Related]  

  • 49. An increased hypothermic response to buspirone in patients with major depression.
    Navinés R; Gómez-Gil E; Martín-Santos R; Martínez de Osaba MJ; Imaz ML; Gastó C
    Psychopharmacology (Berl); 2006 Oct; 188(2):258-60. PubMed ID: 16941120
    [No Abstract]   [Full Text] [Related]  

  • 50. Bupropion and drug-induced parkinsonism.
    Jerome L
    Can J Psychiatry; 2001 Aug; 46(6):560-1. PubMed ID: 11526815
    [No Abstract]   [Full Text] [Related]  

  • 51. Tardive dyskinesia associated with long-term administration of escitalopram and itopride in major depressive disorder.
    Park YM; Lee HJ; Kang SG; Choo CS; Cho JH
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):380-1. PubMed ID: 19121360
    [No Abstract]   [Full Text] [Related]  

  • 52. Bupropion for adults with attention deficit hyperactivity disorder.
    Newcorn JH
    Curr Psychiatry Rep; 2002 Apr; 4(2):86-7. PubMed ID: 12174849
    [No Abstract]   [Full Text] [Related]  

  • 53. Smoking cessation: how to advise the patient.
    Tonstad S
    Heart; 2009 Oct; 95(19):1635-40. PubMed ID: 19752210
    [No Abstract]   [Full Text] [Related]  

  • 54. Galantamine as an adjunctive treatment in major depression.
    Elgamal S; MacQueen G
    J Clin Psychopharmacol; 2008 Jun; 28(3):357-9. PubMed ID: 18480702
    [No Abstract]   [Full Text] [Related]  

  • 55. Sustained administration of bupropion alters the neuronal activity of serotonin, norepinephrine but not dopamine neurons in the rat brain.
    El Mansari M; Ghanbari R; Janssen S; Blier P
    Neuropharmacology; 2008 Dec; 55(7):1191-8. PubMed ID: 18708076
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Varenicline and bupropion sustained-release combination therapy for smoking cessation.
    Ebbert JO; Croghan IT; Sood A; Schroeder DR; Hays JT; Hurt RD
    Nicotine Tob Res; 2009 Mar; 11(3):234-9. PubMed ID: 19246427
    [TBL] [Abstract][Full Text] [Related]  

  • 57. What's new in nicotine & tobacco research?
    Hébert R
    Nicotine Tob Res; 2007 Dec; 9(12):1245-9. PubMed ID: 18058342
    [No Abstract]   [Full Text] [Related]  

  • 58. Emerging drugs for major depressive disorder.
    Kennedy SH; Rizvi SJ
    Expert Opin Emerg Drugs; 2009 Sep; 14(3):439-53. PubMed ID: 19637989
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A case of transient hallucination with ropinirole augmentation antidepressant in a patient with treatment-resistant depression: Is there differential effect of ropinirole dose on developing psychotic symptom?
    Pae CU; Marks DM; Han C; Patkar AA
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):1087-8. PubMed ID: 18384925
    [No Abstract]   [Full Text] [Related]  

  • 60. Perceptual disturbances associated with low-dose bupropion sustained-release treatment.
    Liu CY; Chien YS
    J Clin Psychopharmacol; 2007 Oct; 27(5):543-4. PubMed ID: 17873707
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.